Allianz Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.72M Buy
65,700
+10,200
+18% +$786K ﹤0.01% 1195
2025
Q4
$4.4M Buy
55,500
+2,900
+6% +$229K ﹤0.01% 1193
2025
Q3
$3.97M Sell
52,600
-25,800
-33% -$1.77M ﹤0.01% 1216
2025
Q2
$5.41M Buy
78,400
+34,000
+77% +$2.23M 0.01% 1074
2025
Q1
$3.01M Sell
44,400
-6,700
-13% -$401K ﹤0.01% 1325
2024
Q4
$2.29M Sell
51,100
-8,800
-15% -$494K ﹤0.01% 1377
2024
Q3
$3.77M Buy
59,900
+30,300
+102% +$1.77M 0.01% 1185
2024
Q2
$1.75M Buy
29,600
+26,900
+996% +$1.68M ﹤0.01% 1375
2024
Q1
$215K Sell
2,700
-42,300
-94% -$3.23M ﹤0.01% 1834
2023
Q4
$3.55M Sell
45,000
-76,900
-63% -$5.47M 0.01% 1086
2023
Q3
$8.51M Buy
121,900
+47,000
+63% +$3.33M 0.01% 774
2023
Q2
$5.18M Buy
74,900
+1,500
+2% +$107K 0.01% 855
2023
Q1
$5.45M Buy
73,400
+16,800
+30% +$1.41M 0.01% 937
2022
Q4
$5.27M Buy
56,600
+7,100
+14% +$685K 0.01% 892
2022
Q3
$4.72M Buy
49,500
+7,800
+19% +$772K 0.01% 904
2022
Q2
$3.86M Sell
41,700
-32,400
-44% -$3.16M ﹤0.01% 1186
2022
Q1
$7.5M Buy
74,100
+15,000
+25% +$1.58M 0.01% 1078
2021
Q4
$6.1M Sell
59,100
-21,600
-27% -$2M ﹤0.01% 1160
2021
Q3
$6.85M Buy
80,700
+59,000
+272% +$4.94M 0.01% 1156
2021
Q2
$1.81M Sell
21,700
-21,400
-50% -$1.75M ﹤0.01% 1505
2021
Q1
$3.24M Buy
+43,100
New +$3.14M ﹤0.01% 1230
2020
Q3
Sell
-150,000
Closed -$9.75M 1979
2020
Q2
$9.75M Buy
150,000
+22,900
+18% +$1.44M 0.01% 903
2020
Q1
$7.54M Sell
127,100
-164,300
-56% -$11M 0.01% 972
2019
Q4
$21.6M Buy
291,400
+12,800
+5% +$899K 0.02% 753
2019
Q3
$17.6M Buy
278,600
+37,800
+16% +$2.24M 0.02% 832
2019
Q2
$13.1M Buy
240,800
+81,500
+51% +$4.39M 0.01% 1030
2019
Q1
$8.59M Sell
159,300
-215,800
-58% -$13.3M 0.01% 1215
2018
Q4
$24.6M Sell
375,100
-93,300
-20% -$6.96M 0.03% 611
2018
Q3
$36.9M Sell
468,400
-88,100
-16% -$6.3M 0.03% 558
2018
Q2
$35.8M Buy
556,500
+51,300
+10% +$3.38M 0.03% 554
2018
Q1
$31.4M Sell
505,200
-773,400
-60% -$55.5M 0.03% 627
2017
Q4
$92.7M Buy
1,278,600
+172,400
+16% +$12.5M 0.07% 322
2017
Q3
$90M Buy
1,106,200
+265,500
+32% +$21M 0.08% 304
2017
Q2
$67.6M Sell
840,700
-40,200
-5% -$3.17M 0.07% 353
2017
Q1
$69.2M Sell
880,900
-914,100
-51% -$73M 0.07% 347
2016
Q4
$142M Buy
1,795,000
+682,600
+61% +$55.2M 0.13% 173
2016
Q3
$99M Buy
1,112,400
+228,000
+26% +$21.5M 0.1% 228
2016
Q2
$84.7M Buy
884,400
+381,700
+76% +$38M 0.09% 249
2016
Q1
$52.1M Buy
502,700
+62,400
+14% +$6.07M 0.06% 341
2015
Q4
$43M Buy
440,300
+123,200
+39% +$12.1M 0.05% 447
2015
Q3
$30.6M Sell
317,100
-256,500
-45% -$27M 0.04% 554
2015
Q2
$60.2M Buy
573,600
+169,400
+42% +$17.3M 0.06% 355
2015
Q1
$41.7M Sell
404,200
-51,000
-11% -$5.16M 0.05% 422
2014
Q4
$43.8M Buy
455,200
+283,300
+165% +$25M 0.05% 424
2014
Q3
$13.7M Buy
+171,900
New +$13.6M 0.02% 740

Other funds holding CVS

Allianz Asset Management's CVS Position: Q1 2026 in Review

Allianz Asset Management increased its CVS Health (CVS) stake by 9.7% in Q1 2026, buying an estimated $27.8M and bringing the position to 4,083,392 shares worth $293M. The position accounts for 0.31% of the portfolio, ranked #63.

Allianz Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $404M in Q2 2015. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Allianz Asset Management held 4,083,392 shares of CVS Health worth $293M as of Q1 2026.
  • Allianz Asset Management bought 360,872 CVS Health shares in Q1 2026, an estimated $27.8M.
  • CVS Health made up 0.31% of Allianz Asset Management's portfolio in Q1 2026, its #63 holding.
  • Allianz Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's CVS Health position peaked at $404M in Q2 2015.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.